Ali Behbahani's Net Worth
Ali Behbahani's net worth is estimated to be at least $25,590,607.44 as of 09/03/2025. CoreStreet's estimation of Ali Behbahani's net worth is based on their sale of stock and current holding of stock.
Ali Behbahani is Director at Adaptimmune Therapeutics Plc. They have executed at least 5 trades of stock as per SEC Form 4 filings. Their most recent trade was for 14,671,794 units of ADAP stock on 08/18/2025. Their biggest sale was on 05/25/2022 when they sold 4,445,093 units of Genocea Biosciences Inc stock for $355,607.44. They typically trade 1 times per year.
Total value of insider buys:
- $25,040,000.00
Total value of insider sells:
- $550,607.44
Most recent insider trade:
- Aug. 18, 2025
Ali Behbahani's Insider Trading History
Adaptimmune Therapeutics Plc | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
Aug. 18, 2025 | Director | 14,671,794 | $0.01 | Sell | $146,717.94 |
Aug. 15, 2025 | Director | 4,828,206 | $0.01 | Sell | $48,282.06 |
Sept. 7, 2018 | Director | 12,000,000 | $1.67 | Buy | $20,040,000.00 |
Black Diamond Therapeutics Inc | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
July 5, 2023 | Director | 1,000,000 | $5.00 | Buy | $5,000,000.00 |
Genocea Biosciences Inc | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
May 25, 2022 | Director | 4,445,093 | $0.08 | Sell | $355,607.44 |